Editorial
Tumor-mesenchymal stem cell interactions: therapeutic implications for epithelial ovarian cancer
Translational Cancer Research
2018;
7
(Suppl 7)
:S711-S714
.
(28 August 2018)
Circular RNA HIPK3: an emerging player in diabetes
Translational Cancer Research
2018;
7
(Suppl 7)
:S715-S717
.
(28 August 2018)
Identification of two cancer-associated fibroblast markers revealing stromal heterogeneity in sustaining cancer progression and chemoresistance
Translational Cancer Research
2018;
7
(Suppl 7)
:S718-S721
.
(28 August 2018)
Immature CML cells implement a BMP autocrine loop to escape TKI treatment
Translational Cancer Research
2018;
7
(Suppl 7)
:S722-S725
.
(28 August 2018)
circRNAs and miRNAs in the diagnosis of hepatocellular carcinoma: the long race to new targets
Translational Cancer Research
2018;
7
(Suppl 7)
:S726-S729
.
(28 August 2018)
Casein kinase 1: a new tale of chronic lymphocytic leukemia (CLL) microenvironment
Translational Cancer Research
2018;
7
(Suppl 7)
:S730-S732
.
(28 August 2018)
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue
Translational Cancer Research
2018;
7
(Suppl 7)
:S733-S734
.
(28 August 2018)
Large cohort observational study integrates current knowledge on changes in outcome for melanoma brain metastases in tyrosine kinase inhibitor (TKI)-immunotherapy era
Translational Cancer Research
2018;
7
(Suppl 7)
:S735-S737
.
(28 August 2018)
Prediagnostic genetic stratification for aggressive prostate cancer—is the puzzle for genetic variants gaining shape?
Translational Cancer Research
2018;
7
(Suppl 7)
:S738-S739
.
(28 August 2018)
Are lung adenocarcinoma mutations shaping the immune microenvironment?
Translational Cancer Research
2018;
7
(Suppl 7)
:S740-S742
.
(28 August 2018)
Role of polygenic hazard score in prostate-specific antigen (PSA) screening for prostate cancer
Translational Cancer Research
2018;
7
(Suppl 7)
:S743-S744
.
(28 August 2018)
Circular RNA and exosomes in pancreatic cancer progression
Translational Cancer Research
2018;
7
(Suppl 7)
:S745-S747
.
(28 August 2018)
Epigenetic regulator ARID1A and stem cell transcription factor SOX9 in the maintenance of pancreatic ductal cell differentiation state and development of intraductal papillary mucinous neoplasia (IPMN) and pancreatic ductal adenocarcinoma (PDAC)
Translational Cancer Research
2018;
7
(Suppl 7)
:S748-S751
.
(28 August 2018)
Editorial response to “Clinical complete response to neoadjuvant chemotherapy for muscle-invasive bladder cancer: contemporary outcomes of a multi-institutional cohort study”
Translational Cancer Research
2018;
7
(Suppl 7)
:S752-S754
.
(28 August 2018)
Editorial on “PNLDC1 is essential for piRNA 3' end trimming and transposon silencing during spermatogenesis in mice”
Translational Cancer Research
2018;
7
(Suppl 7)
:S755-S757
.
(28 August 2018)
Circular RNAs: an emerging type of non-coding RNA and their potential implications in bladder cancer
Translational Cancer Research
2018;
7
(Suppl 7)
:S758-S761
.
(28 August 2018)
Editorial on “The genomic landscape of TERT promoter wildtype-IDHwildtype glioblastoma”
Translational Cancer Research
2018;
7
(Suppl 7)
:S762-S765
.
(28 August 2018)
The urea cycle enzymes act as metabolic suppressors in clear cell renal cell carcinoma
Translational Cancer Research
2018;
7
(Suppl 7)
:S766-S769
.
(28 August 2018)
Tumor mutation burden as emerging biomarker in non-small cell lung cancer and beyond
Translational Cancer Research
2018;
7
(Suppl 7)
:S770-S773
.
(28 August 2018)
Immunotherapy in non-small cell lung cancer: steps towards more effective combination therapies
Translational Cancer Research
2018;
7
(Suppl 7)
:S774-S778
.
(28 August 2018)
Targeting ROS1 rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors
Translational Cancer Research
2018;
7
(Suppl 7)
:S779-S786
.
(28 August 2018)
An expanding role for osimertinib for the treatment of ErbB family driven NSCLC
Translational Cancer Research
2018;
7
(Suppl 7)
:S787-S791
.
(28 August 2018)
Crizotinib in ROS1-positive non-small cell lung cancer: an Asian large phase II trial confirms its key-role
Translational Cancer Research
2018;
7
(Suppl 7)
:S792-S795
.
(28 August 2018)
Additive effects of atezolizumab and bevacizumab plus chemotherapy for patients with non-small cell lung cancer regardless of presence of EGFR mutations, ALK rearrangements, or PD-L1 expression
Translational Cancer Research
2018;
7
(Suppl 7)
:S796-S801
.
(28 August 2018)
Bevacizumab as an adjuvant therapy for glioblastoma in elderly patients: the facts
Translational Cancer Research
2018;
7
(Suppl 7)
:S802-S805
.
(28 August 2018)
Meet the Professor
Samuel J. Klempner: approaching gastric cancer questions from different angles increases the chance of success
Translational Cancer Research
2018;
7
(Suppl 7)
:S806-S809
.
(28 August 2018)
Julie D. Saba: pediatric oncology is an amazing field that requires both vigilance and medical acumen
Translational Cancer Research
2018;
7
(Suppl 7)
:S810-S812
.
(28 August 2018)
Charles L. Limoli: the study of brain irradiation is a labor of love
Translational Cancer Research
2018;
7
(Suppl 7)
:S813-S815
.
(28 August 2018)
Louis Dubeau: putting aside biases and validating accustomed dogmas make successful scientists
Translational Cancer Research
2018;
7
(Suppl 7)
:S816-S818
.
(28 August 2018)
Disclosure:
This supplement was published without any sponsorship or funding.
